Known as the “Medical Freedom Act,” House Bill 661 would allow patients suffering from chronic illnesses access to treatments and medications that have yet to be approved by The U.S. Food and Drug Administration.
“Looking at the end of your life, someone you love looking at the end of their life,” said Michelle Wittenburg, who is in that position.
Faced with a diagnosis with no known cure, the 35-year-old mother of two is battling MS while her friends and family are fighting to get access to experimental treatments that could help her.
“I know what’s going to happen to me if I don’t get this experimental drug,” Wittenburg explained.
Chairman of Texans for Cures, David Bales said, “The United States is the greatest leader in medical science and it’s because the FDA makes sure we do it the right way.”
Representative Parker said patients like Jennifer don’t have time to wait for the FDA, and little to lose.
The same kind of therapy Jennifer is getting in Chicago right now through Compassionate Care because stem cell therapy is not FDA-approved.
She added the experimental treatment has given Jennifer hope, “Because I get to change the odds. It gives me the possibility of prolonging my life and prolonging the quality of my life.”
